Research Article
Links between High-Sensitivity C-Reactive Protein and Pulse Wave Analysis in Middle-Aged Patients with Hypertension and High Normal Blood Pressure
Table 1
Demographical and clinical characteristics of the study population (
).
| Characteristics | |
| Age (years) | |
| Gender (male) | 32 (57%) |
| BMI (kg/m2) | |
| SBP (mmHg) | |
| DBP (mmHg) | |
| MAP (mmHg) | |
| Heart rate (beats/minute) | |
| PP (mmHg) | |
| cSYS (mmHg) | |
| cDIA (mmHg) | |
| cPP (mmHg) | |
| TVR () | |
| Augmentation pressure (mmHg) | |
| Augmentation index (AI) (%) | |
| Pulse wave velocity (PWV) (m/s) | |
| PWV increased for age (pathological PWV) | 12 (21.4%) |
| Early arterial aging | 18 (32.1%) |
| Family history of cardiovascular disorders | 13 (22.5%) |
| Cardiovascular risk | High: 17 (30%) | Low: 14 (25%) |
| Hypertension (HT) | High normal: 21 (37.5%) | HT grade 1: 16 (28.6%) | HT grade 2: 13 (23.2%) | HT grade 3: 6 (10.7%) |
| Therapy | ACEI: 17 (30%) | Sartans: 10 (17.5%) | Diuretics: 18 (32.5%) | Beta blockers: 18 (32.5%) | Calcium channel blockers: 4 (7.5%) |
|
|
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure; MAP=mean arterial pressure; PP=pulse pressure; cSYS=central systolic blood pressure; cDIA=central diastolic blood pressure; cPP=central pulse pressure; TVR=total vascular resistance; ACEI=angiotensin converting enzyme inhibitors; HT=hypertension.
|